Botox for stroke recovery: a tiny trial tests whether it can unlock a paralyzed arm

NCT ID NCT03453008

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

Many stroke survivors are left with a stiff, hard-to-move arm due to spastic cocontractions—muscles that contract at the wrong time. This small study tests whether injecting botulinum toxin A into the elbow flexor muscles can reduce those cocontractions and improve active arm movement. Fourteen participants will be evaluated before and after their usual injection to see if the treatment helps restore a functional grip.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
botulinum toxin A injected into elbow flexor muscles
What this could lead to
If successful, this could point toward a better way to restore functional grip in stroke survivors with residual arm weakness.
What could go wrong
This is a very small, early-stage study with only 14 participants, so results may not apply broadly. Botulinum toxin injections carry risks of muscle weakness or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBROVASCULAR ACCIDENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Toulouse

    Toulouse, 31052, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.